A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

Total 497 GIST patients were involved in present study, with a median age of 60 years (range 23–90) and 55.9% was male. Stomach and small bowel were the most common sites of primary disease (59. ...

Bone marrow immunohistochemistry demonstrated positivity for CD3, CD20, CD71, CD61, CD34, MPO, and CD138. Read more about SM diagnosis Bone marrow flow cytometry revealed 29.51% of abnormal myeloid ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Weight loss drugs like Ozempic may be contributing ...

This case series reports on nine patients with diverse clinical presentations and outcomes. Methods: Diagnoses of HS were confirmed using immunohistochemistry, with markers such as CD68 and lysozyme.

GIST may arise anywhere in the GI tract and also in extragastrointestinal locations (extragastrointestinal stromal tumor, EGIST), including ... immunohistochemical (IHC) staining of KIT (CD117 ...

Deregulation of secreted mucin 2 (MUC2) production has provided an important link between inflammation and cancer. Expression of the transmembrane mucin MUC1 is upregulated in response to chronic ...

Characterizing the clinical and genomic features of androgen indifferent prostate cancer. Distribution of manual p53 scores (rows) and automated digital image analysis (DIA) p53 scores (columns) by ...

The vascular markers CD31, ERG, and CD34 were generally ... Furthermore, CAMTA1 or TFE3 immunohistochemistry may provide valuable insights. Moreover, confirming the presence of WWTR1::CAMTA1 or ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...